1:CSII

3 trials

Sponsors

Nanjing First Hospital

Conditions

Type 2 Diabetestype 2 diabetes

Phase 4

Clinical observation on the newly diagnosis of type 2 diabetes mellitus treated with pancreatic kininogenase combined with continuous subcutaneous insulin injection

Active, not recruitingChiCTR1800015918

Nanjing First Hospitaltype 2 diabetes

Start: 2018-05-01Updated: 2018-04-30

The effect of short term intensive treatment with continuous subcutaneous Benaglutide injection combined continuous subcutaneous insulin injection on newly diagnosed type 2 diabetes mellitus

RecruitingChiCTR1800015914

Nanjing First HospitalType 2 Diabetes

Start: 2018-05-03Updated: 2018-04-30

Unknown Phase

The effect of short term intensive treatment by insulin combined with or without Benaglutide with attching pump (equil) for newly diagnosed type 2 diabetes mellitus

Active, not recruitingChiCTR1900020731

Nanjing First HospitalType 2 Diabetes

Start: 2019-03-01Updated: 2019-01-28

Related Papers

Efficacy and safety of beinaglutide with continuous subcutaneous infusion in newly diagnosed patients with type 2 diabetes: a randomized, control, open-labeled clinical trial.

2025-07-28